Page 2 - Monash University Victorian Heart Institute News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Monash university victorian heart institute. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Monash University Victorian Heart Institute Today - Breaking & Trending Today

World's First Drug To Target Untreatable And Deadly 'sticky' Cholesterol

Sydney, Aug 29 (IANS) A new drug offers a breakthrough world first treatment for Lipoprotein(a) a largely genetic form of ‘sticky’ cholesterol that ....

South Australia , Noord Holland , New South Wales , Stephen Nicholls , Monash University , Monash University Victorian Heart Institute , European Society Of Cardiology Congress , European Society , Cardiology Congress , Professor Stephen Nicholls , Victorian Heart Institute , Victorian Heart ,

World's first drug to target untreatable and deadly 'sticky' cholesterol #newkerala(98647)

World's first drug to target untreatable and deadly 'sticky' cholesterol #newkerala(98647)
newkerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newkerala.com Daily Mail and Mail on Sunday newspapers.

South Australia , Noord Holland , New South Wales , Stephen Nicholls , European Society Of Cardiology Congress , Monash University , Monash University Victorian Heart Institute , European Society , Cardiology Congress , Professor Stephen Nicholls , Victorian Heart Institute , Victorian Heart ,

Breakthrough Drug Targets a Form of "Bad Cholesterol"

A clinical trial has demonstrated the success of Muvalaplin, the first oral drug ever developed to target Lipoprotein(a), a largely genetic form of cholesterol that increases the risk of heart attack. ....

South Australia , Noord Holland , Stephen Nicholls , Eli Lilly , Technology Network , European Society Of Cardiology Congress , Monash University Victorian Heart Institute , Monash Victorian Heart Institute , Victorian Heart Hospital At Monash Health , Victorian Heart , Monash University , Victorian Heart Institute , Victorian Heart Hospital , Monash Health , European Society , Cardiology Congress , Cleveland Clinic ,

World's first drug to target untreatable and deadly 'sticky' cholesterol

A new drug offers a breakthrough world first treatment for Lipoprotein(a) a largely genetic form of 'sticky' cholesterol that increases the risk of deadly heart attack and stroke, according to a study.High levels of Lipoprotein(a), is . ....

Noord Holland , South Australia , New South Wales , Stephen Nicholls , Monash University Victorian Heart Institute , Monash University , European Society Of Cardiology Congress , European Society , Cardiology Congress , Professor Stephen Nicholls , Victorian Heart Institute , Victorian Heart ,

World first drug to target form of previously

Simultaneous presentation at European Cardiology Conference and publication in JAMA will detail the world's first oral drug for the treatment of a type of high cholesterol - called Lp(a) - that is a potentially more dangerous version of the so called "bad" cholesterol, LDL, because it is stickier and may be more likely to cause blockages and blood clots in your arteries.

It is estimated that up to 20% of people worldwide have high levels of Lp(a), which is associated with a person's risk of experiencing a heart attack, strokes or other serious cardiac event. Importantly Lp(a) can be present even in younger adults and otherwise healthy people with no other known cardiovascular risks - and often remains undetected until a cardiac event has occurred. ....

South Australia , Noord Holland , Stephen Nicholls , Eli Lilly , Victorian Heart Hospital At Monash Health , Monash Health , Method Of Research , European Society Of Cardiology Congress , Monash Victorian Heart Institute , Monash University , Monash Health Is Victoria , Monash University Victorian Heart Institute , Professor Stephen Nicholls , Victorian Heart Institute , Victorian Heart , Victorian Heart Hospital , European Society , Cardiology Congress , Cleveland Clinic , Heart Hospital , Monash Victorian Heart , Oral Small Molecule Inhibitor , Randomized Clinical ,